April 2017 Price Concessions/NCSO

THIS CONTENT HAS NOW EXPIRED

April 2017 Price Concessions/NCSO

April 12, 2017

The Department of Health has granted the following price concessions for April 2017:

Drug Pack size Price concession
Amitriptyline 50mg tablets 28 £3.50
Buspirone 10mg tablets 30 £9.57
Buspirone 5mg tablets 30 £16.50
Dapsone 50mg tablets 28 £46.19
Diamorphine 30mg powder for solution for injection ampoules 5 £16.52
Ethosuximide 250mg/5ml oral solution 200ml £173.00
Exemestane 25mg tablets 30 £11.50
Leflunomide 10mg tablets 30 £7.76
Lorazepam 1mg tablets 28 £6.00
Mirtazapine 15mg tablets 28 £3.00
Mirtazapine 30mg tablets 28 £1.40
Mirtazapine 45mg tablets 28 £3.00
Nitrofurantoin 100mg tablets 28 £11.20
Nitrofurantoin 50mg tablets 28 £20.50
Oxazepam 10mg tablets 28 £7.97
Oxazepam 15mg tablets 28 £7.97
Pramipexole 88microgram tablets 30 £8.50
Ropinirole 5mg tablets 84 £165.00
Spironolactone 50mg tablets 28 £5.20
Valsartan 160mg capsules 28 £17.25
Valsartan 40mg capsules 28 £8.95
Valsartan 80mg capsules 28 £11.50
Zolmitriptan 2.5mg orodispersible tablets sugar free 6 £15.22
Zolmitriptan 2.5mg tablets 6 £15.30

The price concession only applies to the month that it is granted.

Please note negotiations are still ongoing regarding a number of products. 

Contractors will be alerted to any updates through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession. No additional endorsements are required for price concessions.

If you have problems obtaining a Part VIII product or problems obtaining the product at the set Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.

If you have been able to source the product, please provide full details of the supplier and price paid. PSNC will investigate the extent of the problem and if appropriate discuss the issue with the Department of Health. 

Any further concessions will be posted here on the website.



Posted in:


More Latest News >

Ask PSNC: NUMSAS FAQs

The team at PSNC has received a number of queries on the NHS Urgent Medicine Supply Advanced Service (NUMSAS) since...

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...